Federal Register / Vol. 72, No. 222 / Monday, November 19, 2007 / Notices 65053 

Dated: November 13, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5741 Filed 11–16–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders Special Emphasis Panel, NIDCD 

Clinical Center Review. 

Date: December 10, 2007. 

Time: 12 p.m. to 2:15 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Melissa Stick, PhD, Mph, 

Chief, Scientific Review Branch, Division of 

Extramural Activities, NIDCD/NIH, 6120 

Executive Blvd., Bethesda, MD 20892, 301–

496–8683. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: November 9, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5742 Filed 11–16–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel, MBRS Support of Competitive 

Research. 

Date: November 26–27, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892, (Virtual Meeting). 

Contact Person: C. Craig Hyde, PhD, Office 

of Scientific Review, National Institute of 

General Medical Sciences, National Institutes 

of Health, Building 45, Room 3AN18, 

Bethesda, MD 20892, 301–435–3825, 

ch2v@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: November 8, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5743 Filed 11–16–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: Use of Anti-TAG72 

Monoclonal Antibodies as a TumorSpecific Imaging Agent and Drug 

Delivery Therapeutic 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

Part 404.7(a)(1)(i), that the National 

Institutes of Health, Department of 

Health and Human Services, is 

contemplating the grant of an exclusive 

patent license to practice the inventions 

embodied in the following patents or 

patent applications U.S. Provisional 

Patent Application Nos. 60/106,534 and 

60/106,757 filed October 31, 1998 and 

November 2, 1998; U.S. Patent No. 

6,818,749 issued November 16, 2004; 

and U.S. Patent Application 10/927,433 

filed August 25, 2004 as well as issued 

and pending foreign counterparts [HHS 

Ref. No. E–259–1998/0, /1, and /2]; U.S. 

Provisional Patent Application No. 60/ 

498,903 filed August 29, 2003 and U.S. 

Patent Application No. 10/570,220 filed 

February 28, 2006 as well as issued and 

pending foreign counterparts [HHS Ref. 

No. E–323–2003/0]; U.S. Patent 

Application Nos. 07/510,697 filed July 

17, 1990; 07/964,536 filed October 20, 

1992; 08/261,354 filed June 16, 1994 

and issued as U.S. Patent No. 5,976,531 

on November 2, 1999; 08/487,743 filed 

June 7, 1995; 08/961,309 filed June 30, 

1997 and issued as U.S. Patent No. 

6,495,137 on December 17, 2002; and 

10/255,478 filed September 25, 2002 

and issued as U.S. Patent No. 7,179,899 

on February 20, 2007 as well as issued 

and pending foreign counterparts [HHS 

Ref. E–347–2003/0, /1, /2, and /3]; U.S. 

Patent Application Nos. 07/259,943 

filed October 19, 1988; 07/261,942 filed 

January 28, 1988; 07/424,362 filed 

October 19, 1989; 08/017,570 filed 

February 16 and issued as U.S. Patent 

No. 5,472,693 on December 5, 1995, 

1993; 08/040,687 filed March 31, 1993 

and issued as U.S. Patent No. 6,051,225 

on April 18, 2000; 08/822,028 filed 

March 24, 1997 and issued as U.S. 

Patent No. 5,993,813 on November 30, 

1999; 08/479,285 filed June 7, 1997 and 

issued as U.S. Patent No. 6,207,815 on 

March 27, 2001; 08/823,105 filed March 

24, 1997; and 09/503,653 filed February 

14, 2000 and issued as U.S. Patent No. 

6,641,999 on November 4, 2003 as well 

as issued and pending foreign 


rwilkins on PROD1PC63 with NOTICES